πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 710 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9273121

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9259473

Polymer hydrogel adhesives formed with multiple crosslinking mechanisms at physiologic pH

Northwestern University Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9259386

Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery int

Rani Therapeutics, LLC Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9241981

Use of a food additive based on at least one phytonutrient for stimulating vaccine immunit

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9228002

Leishmania vaccine using sand fly salivary immunogen

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9205073

Method for treating virus infection using derivative of aniline

China Medical University Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9205127

Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a s

Rani Therapeutics, LLC Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9205032

Pressed tablet tissue application box

Ozsoy Organik Ternizlik Urunler Pazarlama Sanayi Ve Ticaret Limited Sirketi Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9193977

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9187426

Organic compounds

Xenon Pharmaceuticals Inc. Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9186417

Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and method

The Regents of the University of California Β· Granted Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9173839

Anionic lipids and lipid nano-structures and methods of producing and using same

The Board of Regents of the University of Oklahoma Β· Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9155759

Heterochain aliphatic poly-N-oxide copolymers and vaccinating agents and drugs based there

OBCHTCHESTVO S OGRANITCHENNOI OTVESTVENNOSTYOU β€œNPO PETROVAKS FARM” Β· Granted Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9149617

Device, system and methods for the oral delivery of therapeutic compounds

Rani Therapeutics, LLC Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9127292

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9121016

Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

Regents of the University of Minnesota Β· Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9096637

Organic compositions to treat HSF1-related diseases

Arrowhead Research Corporation Β· Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9080175

Organic compositions to treat Beta-ENaC-related diseases

Arrowhead Research Corporation Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9078922

Metal-organic frameworks with exceptionally large pore aperatures

The Regents of the University of California Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9060941

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056046

Standardized extract and its use in the manufacture of a medicament

Botanic Century (Beijing) Co. Ltd. Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056130

Humanized Fc gamma R mice

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9043996

Genetically modified major histocompatibility complex animals

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted